Does intestinal dysbiosis contribute to an aberrant inflammatory response to SARS-CoV-2 in frail patients?
In few months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become the main health worldwide problem. Epidemiological studies revealed that population has different vulnerability to SARS-CoV-2: severe outcome of COVID-19, with an increased risk of death, is observed in...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12809
- Palabra clave:
- SARS-CoV-2
COVID-19
Metabolic syndrome
Cardiovascular diseases
Gut dysbiosis
Nutraceuticals
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido